Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Smits, M."" wg kryterium: Autor


Tytuł :
Predicting the 1p/19q Codeletion Status of Presumed Low-Grade Glioma with an Externally Validated Machine Learning Algorithm.
Autorzy :
van der Voort SR; Biomedical Imaging Group Rotterdam, Departments of Radiology and Nuclear Medicine Medical Informatics, Erasmus MC-University Medical Centre Rotterdam, Rotterdam, the Netherlands.
Incekara F; Department of Radiology and Nuclear Medicine, Erasmus MC-University Medical Centre Rotterdam, Rotterdam, the Netherlands.; Department of Neurosurgery, Brain Tumor Center, Erasmus MC-University Medical Centre Rotterdam, Rotterdam, the Netherlands.
Wijnenga MMJ; Department of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Kapas G; Department of Radiology and Nuclear Medicine, Erasmus MC-University Medical Centre Rotterdam, Rotterdam, the Netherlands.
Gardeniers M; Department of Radiology and Nuclear Medicine, Erasmus MC-University Medical Centre Rotterdam, Rotterdam, the Netherlands.
Schouten JW; Department of Neurosurgery, Brain Tumor Center, Erasmus MC-University Medical Centre Rotterdam, Rotterdam, the Netherlands.
Starmans MPA; Biomedical Imaging Group Rotterdam, Departments of Radiology and Nuclear Medicine Medical Informatics, Erasmus MC-University Medical Centre Rotterdam, Rotterdam, the Netherlands.
Nandoe Tewarie R; Department of Neurosurgery, Haaglanden MC, the Hague, the Netherlands.
Lycklama GJ; Department of Radiology, Haaglanden MC, the Hague, the Netherlands.
French PJ; Department of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Dubbink HJ; Department of Pathology, Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
van den Bent MJ; Department of Neurology, Brain Tumor Center, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.
Vincent AJPE; Department of Neurosurgery, Brain Tumor Center, Erasmus MC-University Medical Centre Rotterdam, Rotterdam, the Netherlands.
Niessen WJ; Biomedical Imaging Group Rotterdam, Departments of Radiology and Nuclear Medicine Medical Informatics, Erasmus MC-University Medical Centre Rotterdam, Rotterdam, the Netherlands.; Imaging Physics, Faculty of Applied Sciences, Delft University of Technology, Delft, the Netherlands.
Klein S; Biomedical Imaging Group Rotterdam, Departments of Radiology and Nuclear Medicine Medical Informatics, Erasmus MC-University Medical Centre Rotterdam, Rotterdam, the Netherlands.
Smits M; Department of Radiology and Nuclear Medicine, Erasmus MC-University Medical Centre Rotterdam, Rotterdam, the Netherlands. marion.smits@erasmusmc.nl.
Pokaż więcej
Źródło :
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2019 Dec 15; Vol. 25 (24), pp. 7455-7462. Date of Electronic Publication: 2019 Sep 23.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Algorithms*
Chromosome Deletion*
Machine Learning*
Brain Neoplasms/*genetics
Chromosomes, Human, Pair 1/*genetics
Chromosomes, Human, Pair 19/*genetics
Glioma/*genetics
Magnetic Resonance Imaging/*methods
Brain Neoplasms/pathology ; Brain Neoplasms/surgery ; Cytogenetic Analysis/methods ; Female ; Glioma/pathology ; Glioma/surgery ; Humans ; Isocitrate Dehydrogenase/genetics ; Male ; Middle Aged ; Mutation ; ROC Curve
Czasopismo naukowe
Tytuł :
Value of MRI in medicine: More than just another test?
Autorzy :
van Beek EJR; Edinburgh Imaging facility QMRI, University of Edinburgh, Edinburgh, UK.
Kuhl C; Department of Diagnostic and Interventional Radiology, University of Aachen, Aachen, Germany.
Anzai Y; Department of Radiology, University of Utah, Salt Lake City, Utah, USA.
Desmond P; Royal Melbourne Hospital, University of Melbourne, Melbourne, Australia.
Ehman RL; Department of Radiology, Mayo Clinic, Rochester, Minnesota, USA.
Gong Q; Huaxi MR Research Center (HMRRC), Department of Radiology, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Gold G; Department of Radiology, Engineering and Orthopaedic Surgery, Stanford University, Stanford, California, USA.
Gulani V; Departments of Radiology, Urology and Biomedical Imaging, Case Western Reserve University, University Hospitals of Cleveland, Cleveland, Ohio, USA.
Hall-Craggs M; Department of Medical Imaging and Radiology, University College Hospital NHS Trust, London, UK.
Leiner T; Department of Radiology and Nuclear Medicine, University Medical Centre, Utrecht, The Netherlands.
Lim CCT; Department of Neuroradiology, National Neuroscience Institute and Duke NUS Medical School, Singapore, Singapore.
Pipe JG; Department of Imaging Research, Barrow Neurological Institute, Phoenix, Arizona, USA.
Reeder S; Departments of Radiology, Medical Physics, Biomedical Engineering, Medicine and Emergency Medicine, University of Madison, Madison, Wisconsin, USA.
Reinhold C; Department of Radiology, McGill University Health Center, Montreal, Canada.
Smits M; Department of Radiology and Nuclear Medicine, Erasmus Medical Center, Rotterdam, the Netherlands.
Sodickson DK; Department of Radiology, New York University Langone Health, New York, New York, USA.
Tempany C; Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Vargas HA; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Wang M; Department of Radiology, Henan Provincial People's Hospital, Zhengzhou, Henan, China.
Pokaż więcej
Źródło :
Journal of magnetic resonance imaging : JMRI [J Magn Reson Imaging] 2019 Jun; Vol. 49 (7), pp. e14-e25. Date of Electronic Publication: 2018 Aug 25.
Typ publikacji :
Editorial; Review
MeSH Terms :
Magnetic Resonance Imaging/*economics
Abdomen/diagnostic imaging ; Aged ; Breast/diagnostic imaging ; Contrast Media ; Female ; Geography ; Health Care Costs ; Humans ; Image Processing, Computer-Assisted ; Liver/diagnostic imaging ; Magnetic Resonance Imaging/standards ; Male ; Middle Aged ; Muscle, Skeletal/diagnostic imaging ; Prostate/diagnostic imaging ; Pulmonary Embolism/diagnostic imaging ; Reimbursement Mechanisms ; Research Design ; Young Adult
Recenzja
Tytuł :
The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposal.
Autorzy :
Le Rhun E; Department of Neurology & Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.; University of Lille, France.; Neuro-oncology, Neurosurgery Deparment, CHU Lille, France.; Neurology, Medical oncology Department, Oscar Lambret Center, Lille, France.
Devos P; University Lille, France.
Boulanger T; Imaging Department, Oscar Lambret Center, Lille, France.
Smits M; Department of Radiology and Nuclear Medicine, Erasmus MC-University Medical Center Rotterdam, Rotterdam, Netherlands.
Brandsma D; Department of Neuro-oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, Netherlands.
Rudà R; Department of Neuro-oncology, City of Health and Science and University of Turin, Turin, Italy.
Furtner J; Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Vienna, Austria.
Hempel JM; Radiology Department, Department for Diagnostic and Interventional Radiology, University of Tübingen, Tübingen, Germany.
Postma TJ; Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Neurology, Amsterdam, Netherlands.
Roth P; Department of Neurology & Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.
Snijders TJ; Department of Neurology, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, Netherlands.
Winkler F; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany.; Clinical Cooperation Unit Neuro-oncology, German Cancer Consortium, German Cancer Research Center, Heidelberg, Germany.
Winklhofer S; Department of Neuroradiology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Castellano A; Neuroradiology Department, Vita-Salute San Raffaele University and IRCCS San Raffaele Scientific Institute, Milan, Italy.
Hattingen E; Institute of Neuroradiology, University Hospital Frankfurt/Main, Frankfurt, Germany.
Capellades J; Neuroradiology Department, Hospital del Mar, Barcelona, Spain.
Gorlia T; EORTC Headquarters, Brussels, Belgium.
Van den Bent M; Brain Tumor Center at Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands.
Wen PY; Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Boston, Massachusetts, USA.
Bendszus M; Department of Neuroradiology, University of Heidelberg, Heidelberg, Germany.
Weller M; Department of Neurology & Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.
Pokaż więcej
Corporate Authors :
European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumor Group (BTG) Central Nervous System (CNS) Metastases Committee and the EORTC BTG Imaging Committee
Źródło :
Neuro-oncology [Neuro Oncol] 2019 May 06; Vol. 21 (5), pp. 648-658.
Typ publikacji :
Journal Article
MeSH Terms :
Patient Outcome Assessment*
Clinical Trials as Topic/*standards
Magnetic Resonance Imaging/*methods
Meningeal Neoplasms/*secondary
Neoplasms/*pathology
Neuroimaging/*methods
Adult ; Aged ; Combined Modality Therapy ; Disease Progression ; Feasibility Studies ; Female ; Follow-Up Studies ; Humans ; Male ; Meningeal Neoplasms/cerebrospinal fluid ; Meningeal Neoplasms/therapy ; Middle Aged ; Neoplasms/cerebrospinal fluid ; Neoplasms/therapy ; Survival Rate ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Inter-rater agreement in glioma segmentations on longitudinal MRI.
Autorzy :
Visser M; Department of Radiology and Nuclear Medicine, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands. Electronic address: m..
Müller DMJ; Department of Neurosurgery, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands; Brain Tumor Center, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands.
van Duijn RJM; Department of Radiology and Nuclear Medicine, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands.
Smits M; Department of Radiology and Nuclear Medicine, Erasmus MC, PO Box 2040, 3000 CA Rotterdam, the Netherlands.
Verburg N; Department of Neurosurgery, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands; Brain Tumor Center, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands.
Hendriks EJ; Department of Radiology and Nuclear Medicine, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands.
Nabuurs RJA; Department of Neurosurgery, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands; Brain Tumor Center, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands.
Bot JCJ; Department of Radiology and Nuclear Medicine, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands.
Eijgelaar RS; Department of Radiotherapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1006 BE Amsterdam, the Netherlands.
Witte M; Department of Radiotherapy, The Netherlands Cancer Institute, Plesmanlaan 121, 1006 BE Amsterdam, the Netherlands.
van Herk MB; Institute of Cancer Sciences, Manchester Cancer Research Centre, Division of Cancer Science, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Sciences Centre, Manchester M13 9PL, United Kingdom.
Barkhof F; Department of Radiology and Nuclear Medicine, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands; Institutes of Neurology and Healthcare Engineering, University College London, Gower St, Bloomsbury, London WC1E 6BT, United Kingdom.
de Witt Hamer PC; Department of Neurosurgery, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands.
de Munck JC; Department of Radiology and Nuclear Medicine, Amsterdam UMC, location VUmc, De Boelelaan 1117, 1081 HZ Amsterdam, the Netherlands.
Pokaż więcej
Źródło :
NeuroImage. Clinical [Neuroimage Clin] 2019; Vol. 22, pp. 101727. Date of Electronic Publication: 2019 Feb 22.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Brain Neoplasms/*diagnostic imaging
Glioma/*diagnostic imaging
Magnetic Resonance Imaging/*standards
Adult ; Aged ; Brain Neoplasms/epidemiology ; Cohort Studies ; Female ; Glioma/epidemiology ; Humans ; Magnetic Resonance Imaging/methods ; Male ; Middle Aged ; Netherlands/epidemiology ; Observer Variation ; Random Allocation
Czasopismo naukowe
Tytuł :
Effects of systematic partial volume errors on the estimation of gray matter cerebral blood flow with arterial spin labeling MRI.
Autorzy :
Petr J; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany. .; Department of Biomedical Engineering, Rochester Institute of Technology, Rochester, NY, USA. .
Mutsaerts HJMM; Department of Biomedical Engineering, Rochester Institute of Technology, Rochester, NY, USA.; Sunnybrook Research Institute, Toronto, Canada.; Department of Radiology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands.; Department of Radiology, University Medical Center Utrecht, Utrecht, The Netherlands.
De Vita E; Lysholm Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, London, UK.; Department of Biomedical Engineering, School of Biomedical Engineering and Imaging Sciences, Kings College London, Kings Health Partners, St Thomas Hospital, London, UK.
Steketee RME; Department of Radiology and Nuclear Medicine, Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands.
Smits M; Department of Radiology and Nuclear Medicine, Erasmus MC-University Medical Center Rotterdam, Rotterdam, The Netherlands.
Nederveen AJ; Department of Radiology, Academic Medical Center Amsterdam, Amsterdam, The Netherlands.
Hofheinz F; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.
van den Hoff J; Helmholtz-Zentrum Dresden-Rossendorf, Institute of Radiopharmaceutical Cancer Research, Dresden, Germany.; Department of Nuclear Medicine, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
Asllani I; Department of Biomedical Engineering, Rochester Institute of Technology, Rochester, NY, USA.
Pokaż więcej
Źródło :
Magma (New York, N.Y.) [MAGMA] 2018 Dec; Vol. 31 (6), pp. 725-734. Date of Electronic Publication: 2018 Jun 18.
Typ publikacji :
Journal Article
MeSH Terms :
Echo-Planar Imaging*
Magnetic Resonance Imaging*
Spin Labels*
Brain/*diagnostic imaging
Gray Matter/*diagnostic imaging
Adult ; Cerebrovascular Circulation ; Computer Simulation ; Female ; Healthy Volunteers ; Humans ; Image Interpretation, Computer-Assisted/methods ; Image Processing, Computer-Assisted ; Linear Models ; Male ; Perfusion ; Reproducibility of Results ; Young Adult
Czasopismo naukowe
Tytuł :
The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study.
Autorzy :
Broen MPG; Department of Neurology, Maastricht University Medical Center, Maastricht, Netherlands.; Department of Neurology, The Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, Netherlands.
Smits M; Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands.
Wijnenga MMJ; Department of Neurology, The Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, Netherlands.
Dubbink HJ; Department of Pathology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, Netherlands.
Anten MHME; Department of Neurology, Maastricht University Medical Center, Maastricht, Netherlands.
Schijns OEMG; Department of Neurosurgery, Maastricht University Medical Center, Maastricht, Netherlands.
Beckervordersandforth J; Department of Pathology, GROW-school for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, Netherlands.
Postma AA; Department of Radiology, Maastricht University Medical Center, Maastricht, Netherlands.
van den Bent MJ; Department of Neurology, The Brain Tumor Center at Erasmus MC Cancer Institute, Rotterdam, Netherlands.
Pokaż więcej
Źródło :
Neuro-oncology [Neuro Oncol] 2018 Sep 03; Vol. 20 (10), pp. 1393-1399.
Typ publikacji :
Journal Article; Multicenter Study; Validation Study
MeSH Terms :
Mutation*
Brain Neoplasms/*pathology
Glioma/*pathology
Isocitrate Dehydrogenase/*genetics
Magnetic Resonance Imaging/*methods
Adult ; Aged ; Aged, 80 and over ; Brain Neoplasms/diagnostic imaging ; Brain Neoplasms/genetics ; Chromosomes, Human, Pair 1/genetics ; Chromosomes, Human, Pair 19/genetics ; Female ; Follow-Up Studies ; Glioma/diagnostic imaging ; Glioma/genetics ; Humans ; Image Processing, Computer-Assisted/methods ; Male ; Middle Aged ; Neoplasm Grading ; Retrospective Studies ; Young Adult
Czasopismo naukowe
Tytuł :
Automatic normative quantification of brain tissue volume to support the diagnosis of dementia: A clinical evaluation of diagnostic accuracy.
Autorzy :
Vernooij MW; Radiology and Nuclear Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands; Epidemiology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands. Electronic address: m..
Jasperse B; Radiology and Nuclear Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
Steketee R; Radiology and Nuclear Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
Koek M; Radiology and Nuclear Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands; Medical informatics, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
Vrooman H; Radiology and Nuclear Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands; Medical informatics, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
Ikram MA; Radiology and Nuclear Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands; Epidemiology, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands; Neurology of Erasmus, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
Papma J; Neurology of Erasmus, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
van der Lugt A; Radiology and Nuclear Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
Smits M; Radiology and Nuclear Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands.
Niessen WJ; Radiology and Nuclear Medicine, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands; Medical informatics, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands; Faculty of Applied Sciences, Delft University of Technology, Delft, the Netherlands.
Pokaż więcej
Źródło :
NeuroImage. Clinical [Neuroimage Clin] 2018 Aug 09; Vol. 20, pp. 374-379. Date of Electronic Publication: 2018 Aug 09 (Print Publication: 2018).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Brain/*diagnostic imaging
Dementia/*diagnostic imaging
Magnetic Resonance Imaging/*standards
Aged ; Brain/pathology ; Dementia/pathology ; Diagnosis, Differential ; Female ; Humans ; Magnetic Resonance Imaging/methods ; Male ; Middle Aged ; Organ Size ; Retrospective Studies
Czasopismo naukowe
Tytuł :
The effect of hippocampal function, volume and connectivity on posterior cingulate cortex functioning during episodic memory fMRI in mild cognitive impairment.
Autorzy :
Papma JM; Department of Neurology, Erasmus MC - University Medical Center Rotterdam, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands. .
Smits M; Department of Radiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands.
de Groot M; Department of Radiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Medical Informatics, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands.
Mattace Raso FU; Department of Geriatrics, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands.
van der Lugt A; Department of Radiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands.
Vrooman HA; Department of Radiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Medical Informatics, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands.
Niessen WJ; Department of Radiology, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Medical Informatics, Erasmus MC - University Medical Center Rotterdam, Rotterdam, The Netherlands.; Faculty of Applied Sciences, Delft University of Technology, Delft, The Netherlands.
Koudstaal PJ; Department of Neurology, Erasmus MC - University Medical Center Rotterdam, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands.
van Swieten JC; Department of Neurology, Erasmus MC - University Medical Center Rotterdam, 's-Gravendijkwal 230, 3015 CE, Rotterdam, The Netherlands.
van der Veen FM; Institute of Psychology, Erasmus University Rotterdam, Rotterdam, The Netherlands.
Prins ND; Alzheimer Center, Department of Neurology, VU University Medical Center, Neuroscience Campus, Amsterdam, The Netherlands.
Pokaż więcej
Źródło :
European radiology [Eur Radiol] 2017 Sep; Vol. 27 (9), pp. 3716-3724. Date of Electronic Publication: 2017 Mar 13.
Typ publikacji :
Journal Article
MeSH Terms :
Memory, Episodic*
Cognitive Dysfunction/*physiopathology
Gyrus Cinguli/*physiopathology
Hippocampus/*pathology
Hippocampus/*physiopathology
Magnetic Resonance Imaging/*methods
Nerve Net/*physiopathology
Aged ; Aged, 80 and over ; Atrophy/pathology ; Case-Control Studies ; Cognitive Dysfunction/diagnostic imaging ; Female ; Humans ; Male ; Middle Aged ; Neuropsychological Tests ; Regression Analysis ; Temporal Lobe/physiopathology
Czasopismo naukowe
Tytuł :
Qualitative agreement and diagnostic performance of arterial spin labelling MRI and FDG PET-CT in suspected early-stage dementia: Comparison of arterial spin labelling MRI and FDG PET-CT in suspected dementia.
Autorzy :
Weyts K; Department of Radiology and Nuclear Medicine, Erasmus University Medical Center Rotterdam, 's-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands.
Vernooij M; Department of Radiology and Nuclear Medicine, Erasmus University Medical Center Rotterdam, 's-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands. Electronic address: m..
Steketee R; Department of Radiology and Nuclear Medicine, Erasmus University Medical Center Rotterdam, 's-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands; Alzheimercentrum Zuidwest Nederland, founded by the EMC ('s-Gravendijkwal 230, 3015 CE Rotterdam, NL) and Havenziekenhuis Rotterdam, Haringvliet 2, 3011 TD Rotterdam, The Netherlands. Electronic address: .
Valkema R; Department of Radiology and Nuclear Medicine, Erasmus University Medical Center Rotterdam, 's-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands. Electronic address: .
Smits M; Department of Radiology and Nuclear Medicine, Erasmus University Medical Center Rotterdam, 's-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands. Electronic address: marion.smits@erasmusmc.nl.
Pokaż więcej
Źródło :
Clinical imaging [Clin Imaging] 2017 Sep - Oct; Vol. 45, pp. 1-7. Date of Electronic Publication: 2017 May 19.
Typ publikacji :
Comparative Study; Journal Article
MeSH Terms :
Brain/*diagnostic imaging
Dementia/*diagnosis
Magnetic Resonance Imaging/*methods
Positron Emission Tomography Computed Tomography/*methods
Adult ; Aged ; Artifacts ; Cerebrovascular Circulation ; Dementia/diagnostic imaging ; Diagnosis, Differential ; Female ; Fluorodeoxyglucose F18 ; Humans ; Male ; Middle Aged ; Positron-Emission Tomography ; Spin Labels
Czasopismo naukowe
Tytuł :
Imaging Correlates of Adult Glioma Genotypes.
Autorzy :
Smits M; From the Department of Radiology, Erasmus MC University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, the Netherlands (M.S.); and Brain Tumor Center, Erasmus MC Cancer Center, Rotterdam, the Netherlands (M.J.v.d.B.).
van den Bent MJ; From the Department of Radiology, Erasmus MC University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, the Netherlands (M.S.); and Brain Tumor Center, Erasmus MC Cancer Center, Rotterdam, the Netherlands (M.J.v.d.B.).
Pokaż więcej
Źródło :
Radiology [Radiology] 2017 Aug; Vol. 284 (2), pp. 316-331.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Brain Neoplasms/*diagnostic imaging
Brain Neoplasms/*genetics
Glioma/*diagnostic imaging
Glioma/*genetics
Magnetic Resonance Imaging/*methods
Adult ; Biomarkers, Tumor ; Brain Neoplasms/pathology ; Contrast Media ; Genotype ; Glioma/pathology ; Humans ; Isocitrate Dehydrogenase/genetics ; Mutation/genetics ; Neoplasm Grading ; Prognosis ; Promoter Regions, Genetic ; Tumor Suppressor Proteins/genetics
Czasopismo naukowe
Tytuł :
Comparison of 2D (RANO) and volumetric methods for assessment of recurrent glioblastoma treated with bevacizumab-a report from the BELOB trial.
Autorzy :
Gahrmann R; Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
van den Bent M; Brain Tumor Center at Erasmus MC Cancer Institute Erasmus University Medical Center, Rotterdam, The Netherlands.
van der Holt B; Clinical Trial Center, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
Vernhout RM; Clinical Trial Center, Erasmus MC Cancer Institute, University Medical Center, Rotterdam, The Netherlands.
Taal W; Brain Tumor Center at Erasmus MC Cancer Institute Erasmus University Medical Center, Rotterdam, The Netherlands.
Vos M; Department of Neurology, Medical Center Haaglanden, The Hague, The Netherlands.
de Groot JC; Department of Radiology, University Medical Center Groningen, Groningen, The Netherlands.
Beerepoot LV; Department of Internal Medicine, Elisabeth Tweesteden Ziekenhuis, Tilburg, The Netherlands.
Buter J; Department of Oncology, VU University Medical Center, Amsterdam, The Netherlands.
Flach ZH; Department of Radiology, Isala Clinics, Zwolle, The Netherlands.
Hanse M; Department of Neurology, Catharina Hospital, Eindhoven, The Netherlands.
Jasperse B; Department of Radiology, Antoni van Leeuwenhoek ziekenhuis, Amsterdam, The Netherlands.
Smits M; Department of Radiology and Nuclear Medicine, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
Pokaż więcej
Źródło :
Neuro-oncology [Neuro Oncol] 2017 Jun 01; Vol. 19 (6), pp. 853-861.
Typ publikacji :
Clinical Trial, Phase II; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms :
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Brain Neoplasms/*pathology
Glioblastoma/*pathology
Magnetic Resonance Imaging/*methods
Neoplasm Recurrence, Local/*pathology
Bevacizumab/administration & dosage ; Brain Neoplasms/diagnostic imaging ; Brain Neoplasms/drug therapy ; Contrast Media ; Glioblastoma/drug therapy ; Humans ; Lomustine/administration & dosage ; Neoplasm Recurrence, Local/drug therapy ; Survival Rate ; Treatment Outcome
Czasopismo naukowe
Tytuł :
Functional connectivity and microstructural white matter changes in phenocopy frontotemporal dementia.
Autorzy :
Meijboom R; Radiology and Nuclear Medicine, Erasmus MC - University Medical Centre, Rotterdam, The Netherlands.
Steketee RME; Radiology and Nuclear Medicine, Erasmus MC - University Medical Centre, Rotterdam, The Netherlands.
de Koning I; Neuropsychology, Erasmus MC - University Medical Centre, Rotterdam, The Netherlands.
Osse RJ; Psychiatry, Erasmus MC - University Medical Centre, Rotterdam, The Netherlands.
Jiskoot LC; Neuropsychology, Erasmus MC - University Medical Centre, Rotterdam, The Netherlands.; Neurology, Erasmus MC - University Medical Centre, Rotterdam, The Netherlands.
de Jong FJ; Neurology, Erasmus MC - University Medical Centre, Rotterdam, The Netherlands.
van der Lugt A; Radiology and Nuclear Medicine, Erasmus MC - University Medical Centre, Rotterdam, The Netherlands.
van Swieten JC; Neurology, Erasmus MC - University Medical Centre, Rotterdam, The Netherlands.
Smits M; Radiology and Nuclear Medicine, Erasmus MC - University Medical Centre, Rotterdam, The Netherlands. marion.smits@erasmusmc.nl.
Pokaż więcej
Źródło :
European radiology [Eur Radiol] 2017 Apr; Vol. 27 (4), pp. 1352-1360. Date of Electronic Publication: 2016 Jul 19.
Typ publikacji :
Journal Article
MeSH Terms :
Frontotemporal Dementia/*diagnostic imaging
Frontotemporal Dementia/*pathology
Magnetic Resonance Imaging/*methods
White Matter/*diagnostic imaging
White Matter/*pathology
Adult ; Aged ; Diffusion Tensor Imaging/methods ; Disease Progression ; Female ; Humans ; Male ; Middle Aged ; Netherlands
Czasopismo naukowe
Tytuł :
Magnetic Resonance Imaging-Based Assessment of Gadolinium-Conjugated Diethylenetriamine Penta-Acetic Acid Test-Infusion in Detecting Dysfunction of Convection-Enhanced Delivery Catheters.
Autorzy :
van Putten EH; Department of Neurosurgery, Erasmus MC-University Medical Centre Rotterdam, Rotterdam, The Netherlands. Electronic address: .
Wembacher-Schröder E; Brainlab AG, Feldkirchen, Germany.
Smits M; Department of Radiology, Erasmus MC-University Medical Centre Rotterdam, Rotterdam, The Netherlands.
Dirven CM; Department of Neurosurgery, Erasmus MC-University Medical Centre Rotterdam, Rotterdam, The Netherlands.
Pokaż więcej
Źródło :
World neurosurgery [World Neurosurg] 2016 May; Vol. 89, pp. 272-9. Date of Electronic Publication: 2016 Feb 06.
Typ publikacji :
Clinical Trial, Phase I; Journal Article; Multicenter Study
MeSH Terms :
Catheters*
Magnetic Resonance Imaging*
Brain Neoplasms/*diagnostic imaging
Drug Delivery Systems/*instrumentation
Glioblastoma/*diagnostic imaging
Oncolytic Virotherapy/*instrumentation
Brain/diagnostic imaging ; Brain Neoplasms/therapy ; Cerebrospinal Fluid/diagnostic imaging ; Cerebrospinal Fluid/metabolism ; Contrast Media ; Convection ; Dependovirus ; Drug Delivery Systems/methods ; Equipment Failure ; Gadolinium DTPA ; Glioblastoma/therapy ; Humans ; Karnofsky Performance Status ; Oncolytic Virotherapy/methods ; Risk Factors
Czasopismo naukowe
Tytuł :
Consensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials.
Autorzy :
Ellingson BM; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Bendszus M; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Boxerman J; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Barboriak D; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Erickson BJ; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Smits M; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Nelson SJ; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Gerstner E; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Alexander B; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Goldmacher G; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Wick W; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Vogelbaum M; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Weller M; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Galanis E; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Kalpathy-Cramer J; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Shankar L; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Jacobs P; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Pope WB; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Yang D; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Chung C; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Knopp MV; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Cha S; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
van den Bent MJ; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Chang S; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Yung WK; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Cloughesy TF; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Wen PY; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Gilbert MR; UCLA Neuro-Oncology Program and UCLA Brain Tumor Imaging Laboratory (BTIL), David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., T.F.C.); Department of Radiological Sciences, David Geffen School of Medicine, University of California - Los Angeles, Los Angeles, California (B.M.E., W.B.P.); Department of Neuroradiology, Heidelberg University Hospital, Heidelberg, Germany (M.B.); Department of Diagnostic Imaging, Warrne Alpert Medical School, Brown University, Providence, Rhode Island (J.B.); Department of Neuroradiology, Duke University School of Medicine, Durham, North Carolina (D.B.); Department of Radiology, Mayo Clinic, Rochester, Minnesota (B.J.E.); Department of Radiology, Erasmus MC University, Rotterdam, Netherlands (M.S.); Department of Radiology and Biomedical Imaging, University of California - San Francisco, San Francisco, California (S.J.N., S.C.); Department of Neurology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts (E.G.); Center for Neuro-Oncology, Dana-Farber/Brigham and Women's Cancer Center, Harvard Medical School, Boston, Massachusetts (B.A., P.Y.W.); Medical and Scientific Affairs, ICON Medical Imaging, Warrington, Pennsylvania (G.G., D.Y.); Department of Neurooncology, National Center of Tumor Disease, University Clinic Heidelberg, Heidelberg, Germany (W.W.); Department of Neurological Surgery, Brain Tumor and Neuro-Oncology Center, Cleveland Clinic, Cleveland, Ohio (M.V.); Department of Neurology, University Hospital Zurich, Zurich, Switzerland (M.W.); Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota (E.G.); Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts (J.K.-C.); Division of Cancer Treatment and Diagnosis, National Cancer Institute (NCI), Bethesda, Maryland (L.S., P.J.); Department of Radiation Oncology, University of Toronto and Princess Margaret
Pokaż więcej
Corporate Authors :
Jumpstarting Brain Tumor Drug Development Coalition Imaging Standardization Steering Committee
Źródło :
Neuro-oncology [Neuro Oncol] 2015 Sep; Vol. 17 (9), pp. 1188-98. Date of Electronic Publication: 2015 Aug 05.
Typ publikacji :
Consensus Development Conference, NIH; Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms :
Brain Neoplasms/*pathology
Magnetic Resonance Imaging/*methods
Magnetic Resonance Imaging/*standards
Neuroimaging/*methods
Neuroimaging/*standards
Clinical Protocols/standards ; Clinical Trials as Topic/standards ; Contrast Media/administration & dosage ; Humans ; Image Enhancement
Czasopismo naukowe
Tytuł :
Standardized evaluation of algorithms for computer-aided diagnosis of dementia based on structural MRI: the CADDementia challenge.
Autorzy :
Bron EE; Biomedical Imaging Group Rotterdam, Department of Medical Informatics, Erasmus MC, Rotterdam, The Netherlands; Biomedical Imaging Group Rotterdam, Department of Radiology, Erasmus MC, Rotterdam, The Netherlands. Electronic address: .
Smits M; Department of Radiology, Erasmus MC, Rotterdam, The Netherlands.
van der Flier WM; Alzheimer Center, Department of Neurology, VU University Medical Center, Neuroscience Campus Amsterdam, The Netherlands; Department of Epidemiology & Biostatistics, VU University Medical Center, Neuroscience Campus Amsterdam, The Netherlands.
Vrenken H; Department of Radiology & Nuclear Medicine, VU University Medical Center, Neuroscience Campus Amsterdam, The Netherlands.
Barkhof F; Department of Radiology & Nuclear Medicine, VU University Medical Center, Neuroscience Campus Amsterdam, The Netherlands.
Scheltens P; Alzheimer Center, Department of Neurology, VU University Medical Center, Neuroscience Campus Amsterdam, The Netherlands.
Papma JM; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands; Department of Radiology, Erasmus MC, Rotterdam, The Netherlands.
Steketee RM; Department of Radiology, Erasmus MC, Rotterdam, The Netherlands.
Méndez Orellana C; Department of Radiology, Erasmus MC, Rotterdam, The Netherlands; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.
Meijboom R; Department of Radiology, Erasmus MC, Rotterdam, The Netherlands.
Pinto M; Department of Neurology, Hospital de São João, Porto, Portugal.
Meireles JR; Department of Neurology, Hospital de São João, Porto, Portugal.
Garrett C; Department of Neurology, Hospital de São João, Porto, Portugal; Department of Clinical Neurosciences and Mental Health, Faculty of Medicine, University of Porto, Porto, Portugal.
Bastos-Leite AJ; Department of Medical Imaging, Faculty of Medicine, University of Porto, Porto, Portugal.
Abdulkadir A; Department of Psychiatry & Psychotherapy, University Medical Centre Freiburg, Germany; Department of Neurology, University Medical Centre Freiburg, Germany; Department of Computer Science, University of Freiburg, Germany.
Ronneberger O; BIOSS Centre for Biological Signaling Studies, University of Freiburg, Germany; Department of Computer Science, University of Freiburg, Germany.
Amoroso N; National Institute of Nuclear Physics, Branch of Bari, Italy; Department of Physics, University of Bari, Italy.
Bellotti R; National Institute of Nuclear Physics, Branch of Bari, Italy; Department of Physics, University of Bari, Italy.
Cárdenas-Peña D; Signal Processing and Recognition Group, Universidad Nacional de Colombia, Colombia.
Álvarez-Meza AM; Signal Processing and Recognition Group, Universidad Nacional de Colombia, Colombia.
Dolph CV; Vision Lab, Old Dominion University, Norfolk, VA 23529, USA.
Iftekharuddin KM; Vision Lab, Old Dominion University, Norfolk, VA 23529, USA.
Eskildsen SF; Center of Functionally Integrative Neuroscience and MINDLab, Aarhus University, Aarhus, Denmark.
Coupé P; Laboratoire Bordelais de Recherche en Informatique, Unit Mixte de Recherche CNRS (UMR 5800), PICTURA Research Group, Bordeaux, France.
Fonov VS; McConnell Brain Imaging Centre, Montreal Neurological Institute, McGill University, Montreal, Canada.
Franke K; Structural Brain Mapping Group, Department of Neurology, Jena University Hospital, Germany; Structural Brain Mapping Group, Department of Psychiatry, Jena University Hospital, Germany.
Gaser C; Structural Brain Mapping Group, Department of Neurology, Jena University Hospital, Germany; Structural Brain Mapping Group, Department of Psychiatry, Jena University Hospital, Germany.
Ledig C; Biomedical Image Analysis (BioMedIA) Group, Department of Computing, Imperial College London, UK.
Guerrero R; Biomedical Image Analysis (BioMedIA) Group, Department of Computing, Imperial College London, UK.
Tong T; Biomedical Image Analysis (BioMedIA) Group, Department of Computing, Imperial College London, UK.
Gray KR; Biomedical Image Analysis (BioMedIA) Group, Department of Computing, Imperial College London, UK.
Moradi E; Department of Signal Processing, Tampere University of Technology, Finland.
Tohka J; Department of Signal Processing, Tampere University of Technology, Finland.
Routier A; Inserm U1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, Inria Paris-Rocquencourt, F-75013 Paris, France; Centre d'Acquisition et de Traitement des Images (CATI), Paris, France.
Durrleman S; Inserm U1127, CNRS UMR 7225, Sorbonne Universités, UPMC Univ Paris 06 UMR S 1127, Institut du Cerveau et de la Moelle épinière, ICM, Inria Paris-Rocquencourt, F-75013 Paris, France; Centre d'Acquisition et de Traitement des Images (CATI), Paris, France.
Sarica A; Bioinformatics Laboratory, Department of Medical and Surgical Sciences, Magna Graecia University, Catanzaro, Italy.
Di Fatta G; School of Systems Engineering, University of Reading, Reading RG6 6AY, UK.
Sensi F; National Institute of Nuclear Physics, Branch of Genoa, Italy.
Chincarini A; National Institute of Nuclear Physics, Branch of Genoa, Italy.
Smith GM; Centre for Integrative Neuroscience and Neurodynamics, University of Reading, RG6 6AH, UK; School of Systems Engineering, University of Reading, Reading RG6 6AY, UK.
Stoyanov ZV; Centre for Integrative Neuroscience and Neurodynamics, University of Reading, RG6 6AH, UK; School of Systems Engineering, University of Reading, Reading RG6 6AY, UK.
Sørensen L; Department of Computer Science, University of Copenhagen, Denmark.
Nielsen M; Department of Computer Science, University of Copenhagen, Denmark.
Tangaro S; National Institute of Nuclear Physics, Branch of Bari, Italy.
Inglese P; National Institute of Nuclear Physics, Branch of Bari, Italy.
Wachinger C; Computer Science and Artificial Intelligence Lab, MA Institute of Technology, Cambridge, USA; Massachusetts General Hospital, Harvard Medical School, Cambridge, USA.
Reuter M; Computer Science and Artificial Intelligence Lab, MA Institute of Technology, Cambridge, USA; Massachusetts General Hospital, Harvard Medical School, Cambridge, USA.
van Swieten JC; Department of Neurology, Erasmus MC, Rotterdam, The Netherlands.
Niessen WJ; Biomedical Imaging Group Rotterdam, Department of Medical Informatics, Erasmus MC, Rotterdam, The Netherlands; Biomedical Imaging Group Rotterdam, Department of Radiology, Erasmus MC, Rotterdam, The Netherlands; Imaging Physics, Applied Sciences, Delft University of Technology, The Netherlands.
Klein S; Biomedical Imaging Group Rotterdam, Department of Medical Informatics, Erasmus MC, Rotterdam, The Netherlands; Biomedical Imaging Group Rotterdam, Department of Radiology, Erasmus MC, Rotterdam, The Netherlands.
Pokaż więcej
Corporate Authors :
Alzheimer's Disease Neuroimaging Initiative
Źródło :
NeuroImage [Neuroimage] 2015 May 01; Vol. 111, pp. 562-79. Date of Electronic Publication: 2015 Jan 31.
Typ publikacji :
Comparative Study; Evaluation Study; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms :
Algorithms*
Alzheimer Disease/*diagnosis
Cognitive Dysfunction/*diagnosis
Diagnosis, Computer-Assisted/*methods
Image Interpretation, Computer-Assisted/*methods
Magnetic Resonance Imaging/*methods
Aged ; Aged, 80 and over ; Alzheimer Disease/classification ; Cognitive Dysfunction/classification ; Diagnosis, Computer-Assisted/standards ; Female ; Humans ; Image Interpretation, Computer-Assisted/standards ; Magnetic Resonance Imaging/standards ; Male ; Middle Aged ; Sensitivity and Specificity
Czasopismo naukowe
Tytuł :
Crossed cerebrocerebellar language lateralization: an additional diagnostic feature for assessing atypical language representation in presurgical functional MR imaging.
Autorzy :
Méndez Orellana C; From the Departments of Radiology (C.M.O., M.V., S.K., A.v.d.L., M.S.) Neurology (C.M.O., E.V.-B).
Visch-Brink E; Neurology (C.M.O., E.V.-B) Neurosurgery (E.V.-B., D.S., A.V.), Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Vernooij M; From the Departments of Radiology (C.M.O., M.V., S.K., A.v.d.L., M.S.).
Kalloe S; From the Departments of Radiology (C.M.O., M.V., S.K., A.v.d.L., M.S.).
Satoer D; Neurosurgery (E.V.-B., D.S., A.V.), Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Vincent A; Neurosurgery (E.V.-B., D.S., A.V.), Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
van der Lugt A; From the Departments of Radiology (C.M.O., M.V., S.K., A.v.d.L., M.S.).
Smits M; From the Departments of Radiology (C.M.O., M.V., S.K., A.v.d.L., M.S.) marion.smits@erasmusmc.nl.
Pokaż więcej
Źródło :
AJNR. American journal of neuroradiology [AJNR Am J Neuroradiol] 2015 Mar; Vol. 36 (3), pp. 518-24. Date of Electronic Publication: 2014 Oct 29.
Typ publikacji :
Journal Article
MeSH Terms :
Language*
Magnetic Resonance Imaging*
Brain Mapping/*methods
Brain Neoplasms/*physiopathology
Cerebellum/*physiopathology
Dominance, Cerebral/*physiology
Adult ; Aged ; Female ; Humans ; Language Tests ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Diagnostic classification of arterial spin labeling and structural MRI in presenile early stage dementia.
Autorzy :
Bron EE; Departments of Medical Informatics and Radiology, Biomedical Imaging Group Rotterdam, Erasmus MC - University Medical Center Rotterdam, the Netherlands.
Steketee RM
Houston GC
Oliver RA
Achterberg HC
Loog M
van Swieten JC
Hammers A
Niessen WJ
Smits M
Klein S
Pokaż więcej
Corporate Authors :
Alzheimer's Disease Neuroimaging Initiative
Źródło :
Human brain mapping [Hum Brain Mapp] 2014 Sep; Vol. 35 (9), pp. 4916-31. Date of Electronic Publication: 2014 Apr 03.
Typ publikacji :
Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Cerebrovascular Circulation*
Alzheimer Disease/*diagnosis
Brain/*pathology
Brain/*physiopathology
Image Interpretation, Computer-Assisted/*methods
Magnetic Resonance Imaging/*methods
Aged ; Alzheimer Disease/pathology ; Alzheimer Disease/physiopathology ; Area Under Curve ; Atrophy ; Diagnosis, Differential ; Female ; Frontotemporal Dementia/diagnosis ; Frontotemporal Dementia/pathology ; Frontotemporal Dementia/physiopathology ; Gray Matter/pathology ; Humans ; Linear Models ; Male ; Middle Aged ; Organ Size ; Prospective Studies ; Support Vector Machine
Czasopismo naukowe
Tytuł :
Structural neuroimaging in aging and Alzheimer's disease.
Autorzy :
Vernooij MW; Department of Radiology, Erasmus MC University Medical Center, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands. m. />Smits M
Pokaż więcej
Źródło :
Neuroimaging clinics of North America [Neuroimaging Clin N Am] 2012 Feb; Vol. 22 (1), pp. 33-55, vii-viii.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Aging/*pathology
Alzheimer Disease/*pathology
Brain/*pathology
Magnetic Resonance Imaging/*methods
Neuroimaging/*methods
Humans
Czasopismo naukowe
Tytuł :
Advanced magnetic resonance neuroimaging of language function recovery after aphasic stroke: a technical review.
Autorzy :
Smits M; Department of Radiology, Erasmus MC - University Medical Centre Rotterdam, Rotterdam, The Netherlands. marion.smits@erasmusmc.nl
Visch-Brink EG
van de Sandt-Koenderman ME
van der Lugt A
Pokaż więcej
Źródło :
Archives of physical medicine and rehabilitation [Arch Phys Med Rehabil] 2012 Jan; Vol. 93 (1 Suppl), pp. S4-14.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Recovery of Function*
Speech*
Aphasia/*etiology
Aphasia/*rehabilitation
Magnetic Resonance Imaging/*methods
Stroke/*complications
Aphasia/physiopathology ; Brain/physiopathology ; Diffusion Tensor Imaging ; Humans ; Neuronal Plasticity ; Reproducibility of Results ; Speech Therapy/methods ; Stroke/physiopathology
Czasopismo naukowe
Tytuł :
Functional magnetic resonance imaging to determine hemispheric language dominance prior to carotid endarterectomy.
Autorzy :
Smits M; Department of Radiology, Erasmus MC-University Medical Center Rotterdam, and Department of Neurology, St. Franciscus General Hospital, Rotterdam, The Netherlands. marion.smits@erasmusmc.nl
Wieberdink RG
Bakker SL
Dippel DW
Pokaż więcej
Źródło :
Journal of neuroimaging : official journal of the American Society of Neuroimaging [J Neuroimaging] 2011 Apr; Vol. 21 (2), pp. e162-5.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
Endarterectomy, Carotid*
Magnetic Resonance Imaging*
Aphasia/*surgery
Carotid Stenosis/*surgery
Aged, 80 and over ; Comorbidity ; Dominance, Cerebral ; Humans ; Male ; Tomography, X-Ray Computed
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies